​

Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

OverviewFinancialsChart

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 53.35% institutional investors, 18.94% insiders, and 27.71% retail investors.

ACTU Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockActuate Therapeutics53.35%18.94%27.71%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252531.58%10,401,5922.82%530.37%1935.71%1-50.00%
Dec 31, 20241990.00%10,116,1362547.05%120960.02%1440.00%2-
Sep 30, 202410-382,167-3-10---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2025Bios Equity COF, LP Buy$500.00K
Jun 27, 2025Bios Equity COF, LP Buy$500.00K
Jun 27, 2025Kreis Leslie W. Buy$500.00K
Jun 27, 2025Kreis Leslie W. Buy$500.00K
Jun 27, 2025Fletcher Aaron G.L. Buy$500.00K

Insider Transactions Trends

DateBuySell
2025 Q2--
2014 Q2--
2013 Q2--
2012 Q4--
2012 Q2--

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 53.35%, followed by 18.94% insiders and 27.71% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 63.84%, which Actuate Therapeutics falls below.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools